Answers are grounded in this paper and cite their sources.
Up to recent years, it was generally believed that bronchopleural fistulas and respiratory failure were the principal determinants of postoperative morbidity and mortality of major lung resections. It is nowadays known that these procedures are frequently complicated by postoperative pneumonia (POP). Patient undergoing lobectomy or pneumonectomy carry many risk factors of POP, because of frequent history of tobacco consumption, and possibly associated chronic bronchitis or chronic obstructive pulmonary disease (COPD), neoplastic disease, extrathoracic co-morbidities and poor nutritional status. Postoperative administration of morphinics may further induce hypoventilation with possibly related complications. The exact incidence of POP after lung resection remains paradoxically poorly known; the risk factors and causative pathogens have been rarely investigated and little is known about the microbiology of POP. A detailed analysis of literature [1] allowed us to show that the reported incidence of pneumonia after lung surgery was extremely variable, depending not only on the extent of resection and the type of antibiotic prophylaxis, but also on the modalities of microbiological sampling and on the type of study design (prospective or retrospective). In a previous prospective study by our team, a high incidence of postoperative pneumonia was observed. At multivariate analysis, risk factors for POP were the extent of resection, the male sex, COPD and the intra-operative bronchial colonisation. We also found that POP often occurred early in the postoperative course, and the involved bacteria were mostly community bacteria (Streptococcus pneumoniae or Haemophilus spp.). Furthermore, we observed that, in colonised patients, early POP was often related to colonising bacteria and that a reduced sensitivity or resistance of these pathogens to cefamandol, the second-generation cephalosporin employed for antibioprophylaxis in that study, was a frequent feature [1]. On the basis of these data, we decided to change our antibioprophylaxis, using a short-term (24 h), high-dose (6 g) course of amoxicillin–clavulanate (AC), which targets bacteria most often responsible for preoperative colonisation (at least in our own patient population) and observed a significant decrease in the incidence of both microbiologically documented and non-documented POP, as well as significant decrease in the overall need of postoperative antibiotics [2]. Conversely, the proportion of bacterial documentation among cases of POP, the occurrence of bronchitis, wound infections and empyema, and the need for antibiotherapy for non-respiratory causes did not change [2]. The current issue of the European Journal of Cardio-thoracic Surgery publishes the results of the experience on POP of the team of the Chiba University, who performed a remarkable work in a large clinical series of 626 patients with lung cancer treated by surgery [3]. In their retrospective work, Yamada et al. found that POP occurred in 6.4% of patients, with significant differences among COPD (14.3%) and non-COPD patients (3.6%). Although the technique of sampling of bronchial secretions was not standardised, they found that 12.8% of patients were colonised preoperatively by ‘potentially pathogenic micro-organisms’, and, as expected, this rate was significantly higher in COPD patients (19.9%) than in non-COPD patients (10.9%). As observed also in our initial work, they found that S. pneumoniae and H. influenzae were the micro-organisms more frequently responsible for the initial colonisation. Interestingly, they also found that POP occurred more frequently among colonised patients (11.5% vs 5.7%). However, they failed to find a correlation between the germs responsible for preoperative colonisation and subsequent POP, because the majority of POP was sustained by bacterial species more frequently associated with truly hospital-acquired pneumonia (especially Staphylococcus aureus or Gram-negative bacteria other than Haemophilus spp.). As also suggested by Sethi et al. in a study dealing with exacerbation of COPD [4], Yamada et al. speculated that, in COPD patients, POP resulted more frequently from infection with new pathogens rather than from switch to infection of germs responsible for colonisation, towards whom patients would be likely to have protective immune response. The authors also suggested that the kind of antibioprophylaxis could also have played a role in the particular microbiology of POP they observed. Effectively, we think that the antibioprophylaxis, which was often prolonged in their series, is likely to be responsible for selection of resistant strains. Furthermore, several patients were treated for bacteriologically unproven POP, and we cannot exclude that, in these cases, bacteria such as Haemophilus or Streptococcus sp. were responsible for infection but they could not be grown in culture because of the long-lasting antibioprophylaxis. Thus, we agree with the authors that the study was not designed to establish a correlation between colonisation and infection, and no conclusion can be drawn by their data on this specific topic. With respect to the occurrence of microbiologically unproven postoperative pneumonias, a last commentary is warranted: POP may be difficult to diagnose because of the frequent occurrence of fever, hypoxaemia or abnormal chest X-ray after lung resection, also in patients who do not have POP. In this setting, microbiological analyses are of paramount importance and the availability of adequate samples for microbiology (in our opinion by fibre-optic bronchoscopy rather than by simple sputum collection) is essential. However, these examinations clearly lack absolute sensitivity and, as also suggested by Yamada et al., negative culture does not rule out pneumonia. Thus, we would commend the pragmatic attitude of the authors: POP has to be finally diagnosed (or ruled out) on the basis of clinical, radiological and laboratory investigations and, if diagnosis is established, in the absence of microbiologic documentation, a prompt antibiotherapy (chosen on the basis of parameters related to the patient, the disease and the specific ecology of the institution), has to be started to limit risks in these often fragile patients.
No takes yet. Share an insight, caveat, or question.
Alifano et al. (2009) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: